Her talk at the Indonesian congress compared tirzepatide's clinical trial results with what doctors see in real-world practice.
Recap by typeshit. Post by @drnurulain_abdullah on Instagram.
50:28
DOWNSIZED looks at why appetite and food noise can creep back late in the weekly cycle, and what that may say about whether a GLP-1 is still working.
Avi Roy points to trial data on drugs like Ozempic, including a 16-week study of 73 people where milkshake ratings barely changed despite reduced appetite.
Research presented at the anesthesiology meeting linked GLP-1 use with lower odds of heart attack and other heart problems. It shows an association, not proof of cause.
A short Philstar Life item on PIONEER 8, a trial of oral semaglutide. The material gives only the title, so tap through for the details.
The talk on losing fat while keeping muscle on GLP-1 drugs opens the festival's Harmony in Health series, starting at 10:30.
Viking's oral weight loss candidate VK2735 has moved into late-stage testing, putting another pill in the race against Lilly and Novo.
Loading…